Product Reports Resources Pricing Login Book a demo

Generate Biomedicines

Biotech & Life Sciences · Somerville, United States · Founded 2020 · IPO 2026

Pioneering Generative Biology to create breakthrough medicines

Valuation $2.04B
Revenue $26M

Investors

14 investors on Generate Biomedicines's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series B+ 14 investors entered at this stage
Samsung Life Science Fund
March Capital Partners
Abu Dhabi Investment Authority
Alaska Permanent Fund
T. Rowe Price
ARCH Venture Partners
Pictet
Morningside
Fidelity Investments
Amgen
NVentures
Flagship Pioneering
MAPS Capital Management
Altitude Life Science Ventures

Global footprint

Where Generate Biomedicines has talent and traffic

Workforce by country
5 countries with
team presence
🇺🇸 United States98.8%
🇦🇪 United Arab Emirates0.4%
🇬🇧 United Kingdom0.4%
🇨🇦 Canada0.4%
🇨🇳 China0.4%
5 countries shown
Web traffic by country
19K monthly visits
across markets
🇺🇸 United States77.9%
🏳️ Korea4.7%
🏳️ Republic of4.2%
🇮🇳 India4.2%
🇬🇧 United Kingdom3.2%
Top 5 markets shown

Talent graph

The shape of Generate Biomedicines's talent

Dealroom maps Generate Biomedicines's team person by person — pinpointing the standout operators and scoring them across the six dimensions investors underwrite. The counts and shape below are a public preview; the named individuals and exact scores live in the platform.

29 standout operatorsDealroom-flagged across the org
26 AI specialistsincl. 18 core researchers
334 employees mappedperson by person
DimensionScore
AI Talentlive Score hidden — book a demo
Engineering Score hidden — book a demo
Product Score hidden — book a demo
Go-to-market Score hidden — book a demo
Leadership Score hidden — book a demo
Research Score hidden — book a demo
Book a demo to unlock Generate Biomedicines's exact scores

Source: Dealroom Talent Intelligence. Public profiles show counts and the team's shape only — request a demo for the named individuals, per-person seniority and tenure, and team benchmarks vs peers.

Patent intelligence

$396k patent portfolio · 8 active families

Estimated portfolio value
$396k
0.02% of market cap · 7.4× smaller than top peer Owkin ($3M)
8 active patent families
Where Generate Biomedicines innovates AlgorithmAntigen Binding FragmentAntigen bindingBioinformaticsGlycoprotein

Where Generate Biomedicines concentrates vs peers

Each axis is a top-10 topic across Generate Biomedicines and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Generate Biomedicines

An AI-synthesized read of the highest-engagement posts about Generate Biomedicines on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Generate Biomedicines on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.